prednisolone has been researched along with Syndrome, VKH (Vogt Koyanagi Harada) in 72 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Excerpt | Relevance | Reference |
---|---|---|
" After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 8.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
" The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 7.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
" After prednisolone and methotrexate failed to have the desired effect, he was treated with azathioprine, which caused pancytopenia, and manifested as fever with positive blood culture for a coagulase-negative staphylococcus infection." | 4.12 | Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report. ( Barman, P; Bhattarai, S; Khatri, S; Manandhar, D; Pyakurel, S; Regmi, S; Singh, AK, 2022) |
" The complex immunological response to interferon and ribavirin may induce or exacerbate the autoimmune condition; however, VKH disease is a very rare complication associated with interferon therapy in chronic hepatitis C." | 3.77 | Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C. ( Jang, JY; Jeong, SW; Kim, HS; Kim, SG; Kim, YS; Lee, SH; Lee, YN; Lim, JH; Park, TK, 2011) |
"Prednisolone (200 mg/day) was systemically administered in 10 VKH disease patients with serous retinal detachment at the macular area." | 3.74 | Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease. ( Dong, Z; Hirose, S; Namba, K; Ohno, S; Saito, M; Saito, W; Satoh, H; Yoshida, K, 2008) |
"To clarify the morphologic background of serous retinal detachment with multilobular dye pooling on fluorescein angiography (FA) in acute Vogt-Koyanagi-Harada (VKH) disease." | 3.74 | Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease. ( Kishi, S; Otani, T; Yamaguchi, Y, 2007) |
"We present a case of fetal death in a 28-year-old pregnant woman being treated with intravenous prednisolone for VKH disease." | 3.74 | [Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt-Koyanagi-Harada disease]. ( Ashida, T; Gotoh, N; Ohta, K; Oka, K; Yonezawa, H, 2007) |
"To assess the clinical course, determine the efficacy and safety of oral methotrexate in the control of intraocular inflammation, and evaluate the outcomes of lensectomy-vitrectomy and goniosynechiolysis on pediatric VKH-associated panuveitis." | 3.73 | Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis. ( Aletaha, M; Dehghan, MH; Peyman, GA; Soheilian, M; Yazdani, S, 2006) |
"Limb and truncal ataxia, vestibular dysfunction and perceptive deafness were observed." | 2.38 | [Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies]. ( Hiraki, Y; Kaji, M; Kuboshiro, T; Kuwasaki, N; Shoji, H, 1989) |
"Serous retinal detachment was confirmed on optical coherence tomography (OCT) and fundus fluorescein angiography." | 1.43 | Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome. ( Chew, SK; Levy, J; Lim, LL; Rogers, S, 2016) |
"At the first recurrence, 81% (13 patients) of exudative retinal detachments (ERD) were associated with an initial immunomodulatory treatment conducted ≤6 months (3." | 1.37 | Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease. ( Bodaghi, B; Cohen, D; Errera, MH; Fardeau, C; Gaudric, A; LeHoang, P; Navarro, A; Westcott, M, 2011) |
"Seven patients with VKH syndrome (three men and four women) participated in the study (14 eyes)." | 1.36 | Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease. ( Igarashi, A; Kamiya, K; Otsuki, T; Shimizu, K, 2010) |
"Isolated anterior segment recurrence in VKH disease may occur concomitantly with subclinical choroidal inflammation and requires systemic therapy." | 1.35 | Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease. ( Bacsal, K; Chee, SP; Wen, DS, 2008) |
" Cox-regression analysis showed that the duration of oral corticosteroid treatment for less than 6 months was the only significant risk factor for recurrence of VKH after adjustment for age, gender, and the initial dosage of oral corticosteroid treatment (adjusted odds ratio=8." | 1.35 | Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease. ( Chan, CK; Chan, RP; Lai, TY; Lam, DS, 2009) |
"However, in a pregnant patient with VKH syndrome, the effects of high-dose corticosteroids on the fetus are controversial." | 1.31 | Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids. ( Doi, M; Matsubara, H; Uji, Y, 2000) |
" It is suggested that the dosage of corticosteroid should be adjusted according to the severity of uveomeningitis." | 1.26 | Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease. ( Hayasaka, S; Okabe, H; Takahashi, J, 1982) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (11.11) | 18.7374 |
1990's | 11 (15.28) | 18.2507 |
2000's | 27 (37.50) | 29.6817 |
2010's | 22 (30.56) | 24.3611 |
2020's | 4 (5.56) | 2.80 |
Authors | Studies |
---|---|
Shinagawa, M | 1 |
Namba, K | 5 |
Mizuuchi, K | 4 |
Iwata, D | 3 |
Hase, K | 1 |
Suzuki, K | 2 |
Hirooka, K | 4 |
Kitaichi, N | 4 |
Hiraoka, M | 1 |
Ishida, S | 4 |
Joo, CW | 1 |
Kim, YK | 1 |
Park, SP | 1 |
Khatri, S | 2 |
Regmi, S | 1 |
Pyakurel, S | 1 |
Bhattarai, S | 1 |
Barman, P | 1 |
Manandhar, D | 1 |
Singh, AK | 1 |
Concha-Del Rio, LE | 1 |
Uribe-Reina, P | 1 |
De-La-Torre, A | 1 |
Zhou, M | 1 |
Gu, RP | 1 |
Sun, Z | 1 |
Jiang, CH | 1 |
Chang, Q | 1 |
Xu, GZ | 1 |
Amir, MM | 1 |
Masood, A | 1 |
Khan, Z | 1 |
Hosoda, Y | 1 |
Uji, A | 1 |
Hangai, M | 2 |
Morooka, S | 1 |
Nishijima, K | 2 |
Yoshimura, N | 3 |
Yang, HK | 1 |
Park, KH | 1 |
Kim, JS | 1 |
Hwang, JM | 1 |
Caso, F | 1 |
Rigante, D | 1 |
Vitale, A | 1 |
Costa, L | 1 |
Bascherini, V | 1 |
Latronico, E | 1 |
Franceschini, R | 1 |
Cantarini, L | 1 |
Urzua, CA | 1 |
Velasquez, V | 1 |
Sabat, P | 1 |
Berger, O | 1 |
Ramirez, S | 1 |
Goecke, A | 1 |
Vásquez, DH | 1 |
Gatica, H | 1 |
Guerrero, J | 1 |
Saito, W | 3 |
Takemoto, Y | 2 |
Uno, T | 2 |
Tagawa, Y | 2 |
Hashimoto, Y | 2 |
Fukuhara, T | 1 |
Ohno, S | 5 |
Hashizume, K | 1 |
Imamura, Y | 1 |
Fujiwara, T | 1 |
Machida, S | 1 |
Ishida, M | 1 |
Kurosaka, D | 1 |
Arevalo, JF | 1 |
Lasave, AF | 1 |
Gupta, V | 1 |
Kozak, I | 1 |
Al Harbi, MB | 1 |
Al Rushood, AA | 1 |
Al Dhibi, HA | 1 |
Chew, SK | 1 |
Levy, J | 1 |
Rogers, S | 1 |
Lim, LL | 1 |
Couto, C | 1 |
Schlaen, A | 1 |
Frick, M | 1 |
Khoury, M | 1 |
Lopez, M | 1 |
Hurtado, E | 1 |
Goldstein, D | 1 |
Ibrahimagić, OĆ | 1 |
Smajlović, D | 1 |
Dostović, Z | 1 |
Zvorničanin, J | 1 |
Pašić, Z | 1 |
Salihović Hajdarević, D | 1 |
Horie, Y | 1 |
Chee, SP | 3 |
Jap, A | 2 |
Bacsal, K | 2 |
Hirose, S | 1 |
Yoshida, K | 1 |
Saito, M | 1 |
Dong, Z | 1 |
Satoh, H | 1 |
Hashimoto, T | 1 |
Takizawa, H | 1 |
Yukimura, K | 1 |
Ohta, K | 2 |
Usui, Y | 1 |
Goto, H | 1 |
Sakai, J | 1 |
Takeuchi, M | 1 |
Usui, M | 1 |
Rao, NA | 2 |
Guo, YL | 1 |
Du, Y | 1 |
He, JF | 1 |
Ishihara, K | 1 |
Kita, M | 1 |
Masuda, T | 1 |
Kimura, N | 1 |
Ishibashi, M | 1 |
Ito, M | 1 |
Takahashi, Y | 2 |
Kumamoto, T | 1 |
Keane, PA | 1 |
Sadda, SR | 1 |
Chan, EW | 1 |
Sanjay, S | 1 |
Chang, BC | 1 |
Otsuki, T | 1 |
Shimizu, K | 1 |
Igarashi, A | 1 |
Kamiya, K | 1 |
Gao, X | 1 |
Li, X | 1 |
Errera, MH | 1 |
Fardeau, C | 1 |
Cohen, D | 1 |
Navarro, A | 1 |
Gaudric, A | 1 |
Bodaghi, B | 1 |
Westcott, M | 1 |
LeHoang, P | 1 |
Yamamoto, M | 1 |
Nakamura, M | 1 |
Lim, JH | 1 |
Lee, YN | 1 |
Kim, YS | 1 |
Kim, SG | 1 |
Jeong, SW | 1 |
Jang, JY | 1 |
Kim, HS | 1 |
Lee, SH | 1 |
Park, TK | 1 |
Nakai, K | 1 |
Gomi, F | 1 |
Ikuno, Y | 1 |
Yasuno, Y | 1 |
Nouchi, T | 1 |
Ohguro, N | 1 |
Nishida, K | 1 |
Iwata, NK | 1 |
Hayashi, T | 1 |
Numaga, J | 1 |
Yamamichi, N | 1 |
Sakurai, M | 1 |
Kanazawa, I | 1 |
Taylor, S | 1 |
Lightman, S | 1 |
Yang, MC | 1 |
Huang, AJ | 1 |
Kjeka, O | 1 |
Krohn, J | 1 |
Mawatari, Y | 1 |
Hirata, A | 1 |
Fukushima, M | 1 |
Tanihara, H | 1 |
Soheilian, M | 1 |
Aletaha, M | 1 |
Yazdani, S | 1 |
Dehghan, MH | 1 |
Peyman, GA | 1 |
Luu, CD | 1 |
Yeo, I | 1 |
Agarwal, M | 1 |
Ganesh, SK | 1 |
Biswas, J | 1 |
Yamaguchi, Y | 1 |
Otani, T | 1 |
Kishi, S | 1 |
Yamamoto, Y | 1 |
Yamazaki, T | 1 |
Takano, S | 1 |
Matsumura, A | 1 |
Matsuo, T | 1 |
Masuda, I | 1 |
Ota, K | 1 |
Yamadori, I | 1 |
Sunami, R | 1 |
Nose, S | 1 |
Ostergaard, J | 1 |
Goldschmidt, E | 1 |
Andersen, N | 1 |
Bennett, FM | 1 |
Gotoh, N | 1 |
Yonezawa, H | 1 |
Oka, K | 1 |
Ashida, T | 1 |
Wen, DS | 1 |
Lai, TY | 1 |
Chan, RP | 1 |
Chan, CK | 1 |
Lam, DS | 1 |
Hayasaka, S | 3 |
Okabe, H | 1 |
Takahashi, J | 1 |
Gruich, MJ | 1 |
Evans, OB | 1 |
Storey, JM | 1 |
Bradley, ST | 1 |
Chen, CJ | 1 |
Reusch, C | 1 |
Chang, L | 1 |
Minkus, G | 1 |
Hammer, H | 1 |
Janáky, M | 1 |
Süveges, I | 1 |
Ikeda, K | 1 |
Suzuki, S | 1 |
Ichijo, M | 1 |
Matsuoka, Y | 1 |
Irimajiri, S | 1 |
Watanabe, K | 1 |
Kato, T | 1 |
Ikeda, N | 1 |
Kadoi, C | 1 |
Nagaki, Y | 1 |
McDonald, HR | 1 |
Doi, M | 1 |
Matsubara, H | 1 |
Uji, Y | 1 |
Kotake, S | 1 |
Mizue, Y | 1 |
Sasamoto, Y | 2 |
Goda, C | 1 |
Iwabuchi, K | 1 |
Onoé, K | 1 |
Matsuda, H | 2 |
Nishihira, J | 1 |
Ishihara, M | 1 |
Schalenbourg, A | 1 |
Leys, A | 1 |
De Courten, C | 1 |
Coutteel, C | 1 |
Herbort, CP | 1 |
Lugossy, G | 1 |
Martinez, JA | 1 |
Lopez, PF | 1 |
Sternberg, P | 1 |
Aaberg, TM | 1 |
Lambert, HM | 1 |
Capone, A | 1 |
Mandell, BA | 1 |
Newman, NJ | 1 |
Itho, S | 1 |
Kurimoto, S | 1 |
Kouno, T | 1 |
Harada, T | 1 |
Matsuzaki, S | 1 |
Okada, H | 1 |
Yumiyama, A | 1 |
Majima, Y | 1 |
Liao, HR | 1 |
Juang, CJ | 1 |
Hiraki, Y | 1 |
Kuwasaki, N | 1 |
Shoji, H | 1 |
Kaji, M | 1 |
Kuboshiro, T | 1 |
Phanthumchinda, K | 1 |
Kanchanapongkul, J | 1 |
Locharernkul, C | 1 |
Wakatsuki, Y | 1 |
Kogure, M | 1 |
Oguro, Y | 1 |
Iversen, TH | 1 |
Sverrisson, T | 1 |
4 reviews available for prednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
Allergy against Steroids in Ocular Inflammation.
Topics: Adult; Conjunctivitis, Allergic; Drug Hypersensitivity; Female; Glucocorticoids; Humans; Prednisolon | 2021 |
[Case of Vogt-Koyanagi-Harada disease associated with non-herpetic acute limbic encephalitis with autoantibodies against glutamate receptor epsilon2 in the cerebrospinal fluid].
Topics: Adult; Autoantibodies; Female; Humans; Limbic Encephalitis; Magnetic Resonance Imaging; Prednisolone | 2009 |
[Vogt-Koyanagi-Harada disease].
Topics: Alleles; Autoimmunity; Diagnosis, Differential; HLA-DR Antigens; HLA-DRB1 Chains; Humans; Melanocyte | 2000 |
[Each one case of Vogt-Koyanagi-Harada disease with vestibular and cerebellar ataxia, and multiple cranial nerve palsies].
Topics: Adult; Ataxia; Betamethasone; Cerebellar Ataxia; Cranial Nerve Diseases; Humans; Labyrinth Diseases; | 1989 |
68 other studies available for prednisolone and Syndrome, VKH (Vogt Koyanagi Harada)
Article | Year |
---|---|
The Steroid-Sparing Effect of Adalimumab in the Treatment for the Recurrent Phase of Vogt-Koyanagi-Harada Disease.
Topics: Adalimumab; Cyclosporine; Humans; Prednisolone; Retrospective Studies; Steroids; Uveomeningoencephal | 2023 |
Vogt-Koyanagi-Harada Disease following mRNA-1273 (Moderna) COVID-19 Vaccination.
Topics: 2019-nCoV Vaccine mRNA-1273; COVID-19; Female; Humans; Middle Aged; Prednisolone; Retinal Detachment | 2022 |
Azathioprine Induced Pancytopenia in a Patient with Vogt-Koyanagi-Harada Disease: A Case Report.
Topics: Azathioprine; Humans; Immunosuppressive Agents; Male; Middle Aged; Pancytopenia; Prednisolone; Uveom | 2022 |
Differences in photoreceptor recovery among patients and between different parts of the posterior pole in Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Female; Fluorescein Angiography; Fovea Centralis; Humans; Mac | 2018 |
A Case of Vogt-Koyanagi-Harada Syndrome Mimicking Optic Neuritis.
Topics: Adult; Alopecia; Asian People; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; | 2018 |
Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Choroid Diseases; Cross-Sectional Studies; Dilatation, Patho | 2014 |
Bilateral disc edema in a patient with Vogt-Koyanagi-Harada disease.
Topics: Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Magnetic Resonance Imaging; Papille | 2014 |
Long-lasting uveitis remission and hearing loss recovery after rituximab in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Adolescent; Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; | 2015 |
Earlier immunomodulatory treatment is associated with better visual outcomes in a subset of patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunomodulation; Immunosuppressi | 2015 |
Relationship between choroidal blood flow velocity and choroidal thickness during systemic corticosteroid therapy for Vogt-Koyanagi-Harada disease.
Topics: Adult; Blood Flow Velocity; Choroid; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infus | 2015 |
Choroidal thickening prior to anterior recurrence in patients with Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Anterior Eye Segment; Child; Choroid; Female; Follow-Up Studies; Glucocorticoids; | 2016 |
RETINAL PIGMENT EPITHELIUM UNDULATIONS IN ACUTE STAGE OF VOGT-KOYANAGI-HARADA DISEASE: Biomarker for Functional Outcomes After High-Dose Steroid Therapy.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Betamethasone; Biomarkers; Drug Combinations; Fema | 2016 |
Clinical Outcomes of Patients with Vogt-Koyanagi-Harada Disease Over 12 Years at a Tertiary Center.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Antibiotics, Antitubercular; Child; Ch | 2016 |
Significant role of the choroidal outer layer during recovery from choroidal thickening in Vogt-Koyanagi-Harada disease patients treated with systemic corticosteroids.
Topics: Adolescent; Adult; Choroid; Choroid Diseases; Female; Fluorescein Angiography; Glucocorticoids; Huma | 2015 |
Long-term Outcomes of Limited Vogt-Koyanagi-Harada Syndrome.
Topics: Administration, Oral; Adult; Female; Follow-Up Studies; Glucocorticoids; Humans; Male; Methylprednis | 2016 |
Adalimumab Treatment in Patients with Vogt-Koyanagi-Harada Disease.
Topics: Adalimumab; Adolescent; Adult; Anti-Inflammatory Agents; Child; Female; Glucocorticoids; Humans; Imm | 2018 |
Vogt-Koyanagi-Harada syndrome and hyperhomocysteinemia: Is there a hidden link?
Topics: Autoimmune Diseases; Comorbidity; Electroencephalography; Humans; Hyperhomocysteinemia; Magnetic Res | 2017 |
Prompt therapy reduces the duration of systemic corticosteroids in Vogt-Koyanagi-Harada disease.
Topics: Asian People; Drug Administration Schedule; Glucocorticoids; Humans; Prednisolone; Uveomeningoenceph | 2008 |
Prognostic factors of Vogt-Koyanagi-Harada disease in Singapore.
Topics: Adolescent; Adult; Age of Onset; Aged; Child; Child, Preschool; Female; Glucocorticoids; Humans; Mal | 2009 |
Elevated choroidal blood flow velocity during systemic corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Topics: Adult; Blood Flow Velocity; Choroid; Female; Fluorescein Angiography; Glucocorticoids; Humans; Injec | 2008 |
Vogt-Koyanagi-Harada disease associated with brainstem encephalitis.
Topics: Adult; Anti-Inflammatory Agents; Brain Stem; Encephalitis; Humans; Magnetic Resonance Imaging; Male; | 2009 |
Presumed Vogt-Koyanagi-Harada disease with unilateral ocular involvement: report of three cases.
Topics: Adult; Aged; Choroid Diseases; Deafness; Female; Fluorescein Angiography; Follow-Up Studies; Glucoco | 2009 |
Correlation between sunset glow fundus and initial dosage of corticosteroid in patients with Vogt-Koyanagi-Harada disease.
Topics: Fundus Oculi; Glucocorticoids; Humans; Prednisolone; Prognosis; Retinal Pigment Epithelium; Risk Fac | 2009 |
Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.
Topics: Acute Disease; Adult; Aged; Cysts; Female; Fluorescein Angiography; Glucocorticoids; Humans; Male; M | 2009 |
OCT interpretations.
Topics: Acute Disease; Cysts; Fluorescein Angiography; Glucocorticoids; Humans; Methylprednisolone; Predniso | 2010 |
Headache, red eyes, blurred vision and hearing loss. Diagnosis: Vogt-Koyanagi-Harada syndrome.
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Female; Fluorescein Angiography; Hearing Loss, Se | 2010 |
Usefulness of anterior chamber depth measurement for efficacy assessment of steroid pulse therapy in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anterior Chamber; Axial Length, Eye; Body Weights and Measures; Drug Therapy, Combinati | 2010 |
Development of bullous retinal detachment during systemic corticosteroid treatment.
Topics: Administration, Oral; Central Serous Chorioretinopathy; Diagnostic Errors; Female; Fluorescein Angio | 2011 |
Effect of the duration of immunomodulatory therapy on the clinical features of recurrent episodes in Vogt--Koyanagi--Harada disease.
Topics: Administration, Oral; Adult; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; | 2011 |
Inner retinal changes in acute-phase Vogt-Koyanagi-Harada disease measured by enhanced spectral domain optical coherence tomography.
Topics: Acute Disease; Adult; Female; Fluorescein Angiography; Glucocorticoids; Humans; Infusions, Intraveno | 2011 |
Vogt-Koyanagi-Harada disease occurring during pegylated interferon-α2b and ribavirin combination therapy for chronic hepatitis C.
Topics: Anti-Inflammatory Agents; Antiviral Agents; Drug Therapy, Combination; Female; Fluorescein Angiograp | 2011 |
Choroidal observations in Vogt-Koyanagi-Harada disease using high-penetration optical coherence tomography.
Topics: Acute Disease; Adult; Choroid Diseases; Coloring Agents; Female; Fluorescein Angiography; Glucocorti | 2012 |
Fits and deafness.
Topics: Adult; Anti-Inflammatory Agents; Brain; Deafness; Humans; Magnetic Resonance Imaging; Male; Meningoe | 2002 |
Recurrent anterior uveitis in patients with Vogt-Koyanagi-Harada syndrome.
Topics: Adolescent; Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Age | 2004 |
Bilateral conjunctival nodules: an unusual manifestation of Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Conjunctival Diseases; Diagnosis, Differential; Female; Glucocorticoids; Humans; Iridocycliti | 2004 |
[Vogt-Koyanagi-Harada disease].
Topics: Adolescent; Adult; Diagnosis, Differential; Female; Fluorescein Angiography; Glucocorticoids; Humans | 2005 |
Choroidal dye filling velocity in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Betamethasone; Blood Circulation; Blood Flow Velocity; Choroid; Coloring Agents; Drug Therapy | 2006 |
Management of pediatric Vogt-Koyanagi- Harada (VKH)-associated panuveitis.
Topics: Administration, Oral; Adolescent; Cataract; Cataract Extraction; Child; Child, Preschool; Drug Thera | 2006 |
Correlation between peripapillary atrophy and corticosteroid therapy in patients with Vogt-Koyanagi-Harada disease.
Topics: Adult; Aged; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Drug Administration Schedul | 2008 |
Triple agent immunosuppressive therapy in Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Fundus Ocul | 2006 |
Tomographic features of serous retinal detachment with multilobular dye pooling in acute Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adult; Diagnosis, Differential; Dose-Response Relationship, Drug; Exudates and Transudat | 2007 |
[Case report of recurrent hydrocephalus due to uveo-meningeal syndrome].
Topics: Adult; Female; Humans; Hydrocephalus; Magnetic Resonance Imaging; Prednisolone; Recurrence; Treatmen | 2007 |
Vogt-Koyanagi-Harada syndrome in two patients with immunoglobulin A nephropathy.
Topics: Glomerulonephritis, IGA; Glucocorticoids; Humans; Male; Middle Aged; Prednisolone; Uveomeningoenceph | 2007 |
Vogt-Koyanagi-Harada syndrome in a Greenlandic Inuit.
Topics: Adult; Fundus Oculi; Genotype; Glucocorticoids; Greenland; HLA Antigens; Humans; Inuit; Male; Panuve | 2008 |
VOGT-KOYANAGI DISEASE.
Topics: Adult; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Methylprednisolone; Methylprednis | 1962 |
[Fetal death following high-dose systemic steroid therapy in a pregnant patient with Vogt-Koyanagi-Harada disease].
Topics: Adult; Female; Fetal Death; Glucocorticoids; Humans; Prednisolone; Pregnancy; Pregnancy Complication | 2007 |
Concomitant choroidal inflammation during anterior segment recurrence in Vogt-Koyanagi-Harada disease.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Anterior Eye Segment; Choroiditis; Color | 2008 |
Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt-Koyanagi-Harada disease.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Child; Drug Administration Schedule; E | 2009 |
Systemic corticosteroid treatment in Vogt-Koyanagi-Harada disease.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Betamethasone; Female; Humans; Hydrocortisone; Male; Mid | 1982 |
Vogt-Koyanagi-Harada syndrome in a 4-year-old child.
Topics: Administration, Oral; Child, Preschool; Female; Fundus Oculi; Humans; Infusions, Intravenous; Mening | 1995 |
[Vogt-Koyanagi-Harada syndrome in an Akita-Inu dog. A case report].
Topics: Animals; Dexamethasone; Dog Diseases; Dogs; Drug Therapy, Combination; Male; Prednisolone; Uveomenin | 1994 |
Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Cataract Extraction; Cyclosporine; Drug Therapy, Combination; Female; Humans; Prednisolone; U | 1993 |
How high is high in steroid treatment of Vogt-Koyanagi-Harada syndrome?
Topics: Adult; Anti-Inflammatory Agents; Betamethasone; Humans; Male; Prednisolone; Uveomeningoencephalitic | 1997 |
Concurrent bilateral posterior scleritis and Vogt-Koyanagi-Harada disease in a patient with positive rheumatoid factor.
Topics: Aged; Betamethasone; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Glucocorticoids; Huma | 1997 |
Vogt-Koyanagi-Harada syndrome in an 11-year-old Boy.
Topics: Atropine; Child; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi | 1999 |
Diagnostic and therapeutic challenges.
Topics: Adult; Choroid; Choroiditis; Diagnosis, Differential; Fluorescein Angiography; Follow-Up Studies; Fu | 1999 |
Vogt-Koyanagi-Harada syndrome in a pregnant patient treated with high-dose systemic corticosteroids.
Topics: Adult; Dermoid Cyst; Ear; Eye Abnormalities; Female; Gestational Age; Glucocorticoids; Humans; Infan | 2000 |
High-dose corticosteroid administration induces increase of serum macrophage migration inhibitory factor in patients with Vogt-Koyanagi-Harada's disease.
Topics: Administration, Oral; Anti-Inflammatory Agents; Dose-Response Relationship, Drug; Glucocorticoids; H | 2000 |
Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adult; Chorioretinitis; Cyclosporine; Drug Therapy, C | 2002 |
[Vogt-Koyanagi-Harada syndrome and cortisone].
Topics: Administration, Topical; Anti-Inflammatory Agents; Arthritis, Rheumatoid; Female; Humans; Hydrocorti | 1976 |
Vogt-Koyanagi-Harada syndrome in patients with Cherokee Indian ancestry.
Topics: Adolescent; Adult; Female; Georgia; Haplotypes; Histocompatibility Testing; HLA Antigens; Humans; In | 1992 |
Vogt-Koyanagi-Harada disease in monozygotic twins.
Topics: Adult; Diseases in Twins; Female; Fluorescein Angiography; Fundus Oculi; Humans; Pedigree; Prednisol | 1992 |
[Occurrence of optic disk hemorrhage in the course of Vogt-Koyanagi-Harada syndrome].
Topics: Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Fluorescein Angiography; Huma | 1991 |
Studies on corticosteroid therapy in Vogt-Koyanagi-Harada disease.
Topics: Administration, Topical; Adolescent; Adrenal Cortex Hormones; Adult; Anterior Chamber; Betamethasone | 1990 |
Formation of pseudodiscs in chronic recurrent Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Choroid; Fluorescein Angiography; Humans; Male; Optic Disk; Prednisolone; Recurrence; Retinal | 1989 |
Vogt-Koyanagi-Harada syndrome.
Topics: Adult; Female; Humans; Male; Middle Aged; Prednisolone; Uveitis; Uveomeningoencephalitic Syndrome | 1989 |
Combination therapy with cyclosporin A and steroid in severe case of Vogt-Koyanagi-Harada's disease.
Topics: Cyclosporins; Drug Therapy, Combination; Humans; Male; Middle Aged; Prednisolone; Time Factors; Uvei | 1988 |
Vogt-Koyanagi-Harada syndrome. A case report.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents; Female; Fluoresce | 1986 |